Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
NCT ID: NCT05968053
Last Updated: 2025-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2023-09-25
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Neurosurgery is the only department that can open the skull. In addition to blood and cerebrospinal fluid, there are brain tissue and tumors in the presence of lesions. Whether any of these microplastics and nanoplastics are present remains a mystery. This prospective observational study will harvest biological samples of neurosurgery patients.
The objective of this research is to be able to detect microplastics and nanoplastics on blood and operation samples of neurosurgery patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
NCT02740933
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NCT04545177
Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling
NCT05943262
Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
NCT06282224
Indocyanine Green for Central Nervous System Tumors
NCT02710240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biological samples analysis
biological samples analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any type of neurosurgery
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaolin Chen, MD
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Runting Li, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tiantan Hospital
Yitong Jia, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tiantan Hospital
Ke Wang, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tiantan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DT-MiNi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.